Ontario-based Inflamax Research Inc. has entered into a strategic alliance with Japan's leading CRO, the InCROM Group, to bring Inflamax Research's next generation Mobile Environmental Exposure Chamber (mEEC) system to Japan.
This strategic alliance will allow Japanese and non-Japanese clients access to technology and expertise in developing new therapies for the treatment of allergic disease toward the Japanese market.
Inflamax claims that the company's mEEC system will be the only mobile EEC system available in Japan for the conduct of multi-center EEC studies. Additionally, Inflamax's mEEC system is also said to be validated for allergens not currently available in Japan such as house dust mite and cat, in addition to Japanese Cedar & Cypress, Birch and Oak Trees, Grass and Ragweed.
The mEEC is a facility designed to expose patients to controlled levels of airborne allergen, similar to those experienced in their daily lives, while reducing the variability of results, and increasing patient compliance compared to typical field trials. The mEECTM was created to meet the regulatory need for geographic diversity across large multi-centre clinical trials that are suitable and required for late phase clinical research.
